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Abstract
Background: Structural variants (SVs) are known to play important roles in a variety of cancers, but their origins
and functional consequences are still poorly understood. Many SVs are thought to emerge from errors in the repair
processes following DNA double strand breaks (DSBs).
Results: We used experimentally quantified DSB frequencies in cell lines with matched chromatin and sequence
features to derive the first quantitative genome-wide models of DSB susceptibility. These models are accurate and
provide novel insights into the mutational mechanisms generating DSBs. Models trained in one cell type can be
successfully applied to others, but a substantial proportion of DSBs appear to reflect cell type-specific processes.
Using model predictions as a proxy for susceptibility to DSBs in tumors, many SV-enriched regions appear to be
poorly explained by selectively neutral mutational bias alone. A substantial number of these regions show
unexpectedly high SV breakpoint frequencies given their predicted susceptibility to mutation and are therefore
credible targets of positive selection in tumors. These putatively positively selected SV hotspots are enriched for
genes previously shown to be oncogenic. In contrast, several hundred regions across the genome show
unexpectedly low levels of SVs, given their relatively high susceptibility to mutation. These novel coldspot regions
appear to be subject to purifying selection in tumors and are enriched for active promoters and enhancers.
Conclusions: We conclude that models of DSB susceptibility offer a rigorous approach to the inference of SVs
putatively subject to selection in tumors.
Keywords: Double strand break, Cancer, Structural variation, Chromatin, Modeling
Background
Structural variation (SV) in tumor genomes is known to
play important roles in disease progression and may be
critical in driving the development of certain cancer
types [1–3]. However, challenges remain not only in as-
certaining accurate SV calls, as evidenced by the com-
pendium of SV calling algorithms used in many projects
[4–6], but also in predicting their functional impact.
Some SVs have apparently direct consequences; for
example, amplification of oncogenes leading to overex-
pression, deletion of tumor suppressors leading to
dysfunction, and translocations generating oncogenic fu-
sion proteins [4]. Reportedly indirect consequences of
SVs include changes in enhancer targeting, affecting the
expression of nearby genes, or “enhancer hijacking” [7].
However, it remains challenging to distinguish the influ-
ences of evolutionary selection versus primary mutation
rate in generating the SVs concerned.
A recent study of whole genome sequencing (WGS)
data from breast tumors identified SV hotspots and pu-
tative driver SVs, but could not discern the relative con-
tributions of mutational bias and selection underlying
these hotspots [8]. Resolving the influences of muta-
tional bias versus selective forces has become critical
given that both single nucleotide variant (SNV) and SV
mutation rates vary widely across the genome, in parallel
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with replication timing and chromatin structure [9, 10].
In analyses of tumor SNVs, variants are routinely priori-
tized based on algorithms including corrections for esti-
mates of SNV mutation rate variation [11], but
analogous methods are not yet applied to SVs.
Variable rates of SVs observed across the genome are
likely to be affected by differences in the efficiency of re-
pair of DNA double strand breaks (DSBs). DSBs can be
repaired by homologous recombination (HR) at the G2
and S stages of the cell cycle and, more commonly, by
canonical non-homologous end joining (c-NHEJ) which
operates throughout the cell cycle [12]. The c-NHEJ
process is error prone and has been shown to create
structural variants initiating carcinogenesis [13]. A third
repair process, alternative NHEJ (alt-NHEJ) uses micro-
homology to mediate repairs when the c-NHEJ pathway
is unavailable, and repair by alt-NHEJ appears to in-
crease the rate of deletions, insertions, and transloca-
tions further [14]. The efficiency of these repair
processes is often dependent upon the chromatin fea-
tures and nuclear organization present where the dam-
age occurs. For example, the histone modification
H3K36me3, associated with active transcription, recruits
the HR pathway, while H4K20me1, a mark of highly
transcribed genes, recruits components of the NHEJ
pathway [15]. The associations between DSB repair and
the underlying chromatin landscape may, therefore, ex-
plain the observed correlations between tumor SV rates
and chromatin structure [9].
Previous studies have also shown DSB formation to be
influenced by underlying chromatin structures and gen-
omic sequences. It has long been known that certain cy-
togenetically mapped loci, termed “fragile sites” undergo
recurrent DSBs in cells under replicative stress and in
cancer [16]. More recent high-throughput sequencing
(HTS)-based approaches have been developed to profile
DSB rates more precisely within in vitro populations of
cells [17–25]. Three of these methods, BLESS [18],
DSBCapture [22], and BLISS [25], are closely related and
have been used to generate high-resolution maps of
endogenous DSBs occurring in human cell lines, result-
ing in continuous data reflecting the propensities for
DSBs across all chromosomes. These studies have
suggested that DSBs may preferentially occur within
nucleosome-depleted regions, are correlated with active
promoter and enhancer histone modifications, and may
associate with G-quadruplex sites [22, 26]. Certain stud-
ies have also suggested DSBs to be depleted in some
transposon classes and enriched in some simple repeat
classes and to be unusually frequent in long,
late-replicating genes [18, 24]. Overall, previous studies
have found correlations and enrichments between DSBs
and various inter-correlated chromatin and genomic fea-
tures, making it difficult to accurately assess the
contribution of any particular feature to DSB susceptibil-
ity. Understanding such contributions can be valuable
for understanding the underlying mutational and repair
mechanisms. In addition, a fuller understanding of the
relative contributions of many features to DSB formation
can allow reliable predictions of the expected DSB fre-
quency in a given genomic region.
Random forests have been used to model a variety of
biological phenomena because they perform well in the
presence of inter-correlated input variables showing
non-linear relationships. For example, they have been
used to predict nuclear compartments [27], cancer SNV
mutational landscapes [28], and enhancer-promoter in-
teractions [29]. In this study, we construct random forest
regression models to generate quantitative measures of
the relative importance of a variety of matched chroma-
tin and other features to DSB susceptibility. We use
multiple, high-resolution DSB profiling datasets to com-
pare modeling accuracy across several platforms and cell
types. The cell types selected have also been extensively
profiled for a variety of chromatin features by the EN-
CODE Project [30] and others, allowing well-matched
models to be constructed for all datasets. We demon-
strate that these models provide accurate estimates for
the expected rate of DSBs in a given region and can be
cross applied between DSB datasets. In addition, the
models can be used to explore tumor SV breakpoint
data, to nominate novel regions putatively subject to se-
lection in cancer.
Results
We uniformly processed four DSB datasets from three
related platforms (DSBCapture and BLISS are both
based upon modifications to the BLESS protocol) and
covering three different cell types, collating matched
chromatin data for each. These datasets include two
novel DSB mapping datasets derived from the K562
erythroleukemia and MCF7 breast cancer cell lines using
the recently developed BLISS method [25] (see the
“Methods” section) and two previously published DSB
mapping datasets derived from the NHEK keratinocyte
cell line using BLESS and DSBCapture [22] protocols.
DSB frequency is defined in each dataset as the number
of unique reads mapping to a given 50 kb region, since
each read in a DSBCapture, BLESS, or BLISS experiment
represents an exposed DNA DSB end. Replicate experi-
ments within each dataset were strongly and signifi-
cantly correlated (Pearson’s r = 0.905 to 0.992, p < 2.2e
−16) and were combined to reduce noise, although ran-
dom forest models generated from any single one of the
replicates yielded very similar results (see the “Methods”
section). Comparisons among DSB profiling datasets
showed moderate correlations in genome-wide DSB fre-
quency between the three cell types as expected (r =
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0.351 to 0.635, p < 2.2e−16), shown in Additional file 1: Fig-
ure S1. All three cell types correspond to well-characterized
ENCODE cell lines, providing numerous matched chroma-
tin and genomic features exhibiting a range of correlations
to DSB (Fig. 1), and are also inter-correlated themselves
(Additional file 1: Figure S2).
Accurate models of genome-wide DSB frequency across
cell types
We modeled DSB frequency at 50 kb resolution, using the
same ten matched genomic features from each cell type to
construct random forest models (see the “Methods” sec-
tion): open chromatin assayed by DNase-seq, POL2B
binding, CTCF binding and five histone modifications
assayed by ChIP-seq, replication timing assayed by
Repli-seq, and RNA-seq. We also included G-quadruplex
forming regions as an additional feature, since these DNA
secondary structures are associated with genomic instabil-
ity [31]. We found strong and significant correlations be-
tween predicted and observed DSB frequency for all four
datasets, with Pearson’s coefficients ranging from 0.83 to
0.92 (Fig. 2). We also generated a model for the NHEK
DSBCapture dataset using an extended set of 21 features,
including additional histone modifications, histone vari-
ants, and nuclear compartmentalization from Hi-C data
[32]. This extended model resulted in better predictive re-
sults for a small fraction of the genome (Additional file 1:
Figure S4, Box B), and a modestly increased genome-wide
Pearson’s coefficient between predicted and observed
values (11 feature model r = 0.918, 21 feature model r =
0.922). We conclude that models constructed using the 11
selected genomic features (Fig. 2) provide high predictive
accuracy across cell types, with additional features likely
to provide only marginal gains.
Variable importance metrics for these models reveal
consistent trends in the most influential features in DSB
frequency prediction (Fig. 2e–h). Replication timing is
the most important feature across all three models with
early replication associated with high DSB regions and
late replication with low DSB (Fig. 3c), in agreement
with previous studies [33]. In addition, the histone modi-
fications H3K36me3 and H3K9me3 (demarcating active
Fig. 1 DSB frequency and genomic features display similar patterns. The tracks show DSBCapture profiles in NHEK cells, BLESS profiles in NHEK
cells, BLISS in K562 cells, and BLISS in MCF7 cells. All tracks are at 50 kb resolution over a representative region of chromosome 1, with a variety of
chromatin and sequence features to illustrate the similarities between them. Numbers in parenthesis are the Spearman’s rho between the
associated track and the NHEK DSBCapture 1 dataset
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genes and gene-poor heterochromatin respectively)
emerge as informative features, with H3K36m3 enriched
in high DSB regions and H3K9me3 in low DSB regions
(Fig. 3c). This is consistent with observations that struc-
tural variants disproportionately accumulate within the
early replicating, relatively gene-rich regions of the
genome in cancer, and are relatively depleted in late rep-
licating heterochromatin [9, 10]. DNase-seq open chro-
matin ranks second in three datasets and fourth in the
MCF7 model and is also the most important feature for
predicting DSB peaks in the study of Mourad et al. [34]
in which they do not include replication timing. The
influence of G-quadruplex forming regions is notably
variable, ranking as a relatively important feature in the
NHEK datasets, but having little and no predictive value
in the K562 and MCF7 datasets. RNA-seq is not a
strong predictor of DSB susceptibility although
DNase-seq peaks are often found at the promoter
regions of active genes. This suggests that open chroma-
tin at transcriptionally active genes and associated
regulatory elements (reflected in DNase-seq, H3K4me3,
and POL2B binding), rather than transcription per se, is
the dominant influence on DSB frequency. CTCF bind-
ing also appears to be an informative variable,
genome-wide in all models, though it binds at sites con-
stituting a very small fraction of the genome. Given the
critical roles of CTCF in chromatin architecture and
regulation [32], there has been intense interest in the
causes and effects of structural variants disrupting
CTCF binding sites [35, 36].
Influential features underlying DSB frequency differ
between genomic loci and cell types
Beyond the general, genome-wide trends described
above, we see differences in the behavior of certain clas-
ses of loci. These are evident as regions departing from
the linear relationship between observed and predicted
DSB frequency seen for the majority of the genome
(Fig. 3a; Additional file 1: Figure S4). Deeper exploration
of the relationships between underlying genomic fea-
tures and DSB frequency reveals diagnostic features for
these discrepant classes. One class of loci (Fig. 3, Box A)
shows unusually low values for both predicted and ob-
served DSB frequencies and is enriched for H3K9me3
marked heterochromatin and low sequence mappability
(Fig. 3b). These regions are likely to correspond to
repeat-rich regions near centromeres and on the short
arms of acrocentric chromosomes, which are problem-
atic for read mapping algorithms [37]. Another class of
H3K9me3 heterochromatin enriched loci shows higher
DSB predictions than observed, in spite of high mapp-
ability values (Fig. 3, Box B). This class of regions is ab-
sent in DSB datasets generated by the BLISS protocol
(Fig. 2), so these aberrant predictions may reflect tech-
nical and methodological differences between datasets.
In any case, it is clear that model predictions may rea-
sonably be expected to be less accurate in heterochro-
matic regions.
The similarities in relative variable importance across
datasets (Fig. 2) suggest that many features have a simi-
lar influence on DSB frequency in each of the three cell
Fig. 2 Accurate models of DSB frequency built from chromatin and sequence features. a–d Random forest regression model predictions built
upon 11 genomic features at 50 kb resolution compared to observed DSB frequencies for four datasets: NHEK DSBCapture, NHEK BLESS, K562
BLISS, and MCF7 BLISS. The y values reflect the sequencing depth of each dataset. The models’ predictions are all highly correlated with the
observed data, as shown by the noted Pearson’s correlations (p < 2.2e−16 for each dataset). e–h The predictive features ranked by variable
importance, a measure of how useful a particular feature is for the model (see the “Methods” section)
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types. Thus, a model trained in one cell type might
generalize well to another cell type and allow us to gen-
erate predictive DSB frequency profiles for model cell
lines currently lacking high-resolution DSB data. We
cross-applied models and found models trained in one
cell type often performed well in another (Fig. 4). For ex-
ample, a model trained in NHEK cells could be used to
predict DSB frequencies in K562 cells (inputting K562
genomic features) with high accuracy (Pearson’s r = 0.85
correlation; Fig. 4). This offers a substantial improve-
ment over the base correlation (r = 0.63) between NHEK
and K562 observed DSB profiles. We measured the cor-
relation of observed and predicted DSB frequencies
across all nine model and feature combinations and al-
ways found correlations (r = 0.58 to 0.85) that improved
on the base correlations (r = 0.38 to 0.63) seen between
the observed DSB datasets (Fig. 4). These improvements
echo the similarities in variable importance between cell
types (Fig. 2). The moderate correlations between DSB
across cell types demonstrate that a substantial propor-
tion of DSB susceptibility across the genome is cell type
specific, which is consistent with the established cell
type-specific properties of many SV breakpoint regions
in tumors, such as common fragile sites [38]. Further-
more, the larger performance gap in models for cell lines
with altered variable rankings indicates that DSB mecha-
nisms may differ across cell types and may not be com-
pletely captured via epigenomic features.
Tumor SV breakpoints possess variable susceptibility to
DSBs
Keratinocytes are considered to be the cell type of origin
for mucosal and cutaneous carcinomas, particularly
squamous cell carcinomas [39], and NHEK cells are
often used in the literature as a model for these cancers.
Similarly, MCF7 cells and K562 cells have been used
Fig. 3 Modeling accuracy and the polarity of genomic features. a NHEK DSBCapture 50 kb regions data is split into three distinct groups with
differing modeling accuracies. b, c The values of the model features for the two boxes, a and b, and for group c, which contains randomly
chosen points along the spectrum of DSB frequency values for the majority of the genome. The columns are ordered by observed DSB
frequency, shown on the top row, and the rows for features used to build the model (the third to second to the last row) are ordered by
average variable importance. The number of 50 kb regions in each group is shown in parenthesis above each heatmap. Each feature was
normalized, setting the 1st to 99th quantiles to values between 0 and 1, with high outliers (in the top percentile) set to 1.1. b Group A has high
H3K9me3 and low mappability scores, indicative of heterochromatin and repetitive sequence, while b has feature patterns that closely match low
DSB values in group c. c For most of the genome, high H3K9me3 corresponds to low DSB regions, and high, or early, replication timing values
and open chromatin values signify high DSB regions
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extensively as models for breast and blood cancers re-
spectively. This motivated us to ask how the DSB
models for these three cell types relate to the patterns of
SV breakpoints observed in squamous cell carcinomas,
blood cancers, and breast tumors.
A number of large structural variant (SV) collections
have been established for a variety of tumor types, and
each possesses advantages and shortcomings. The
International Cancer Genome Consortium (ICGC) pro-
vides high-resolution SV calls based upon whole gen-
ome sequencing (WGS) for 2146 patients across 17
cohorts [40], but sample cellularities, sequencing
depths, and SV calling methods vary across cancer co-
horts and are expected to affect results (Additional file 1:
Figure S6). The Cancer Genome Atlas (TCGA) pro-
duced consistently processed copy number variant
(CNV) calls from SNP chip data for 23,084 patients
across 33 cohorts (Additional file 1: Figure S7). How-
ever, breakpoint resolution is much lower than calls
based upon WGS, and copy neutral SVs such as inver-
sions and translocations are absent. We analyzed ICGC
and TCGA data as pancancer datasets, combining all
cancer types together, but also as three cancer type sub-
groups. TCGA subgroups comprised a squamous cell
carcinoma subgroup, a blood cancers subgroup includ-
ing two blood cancers, and breast cancer as a separate
group (see the “Methods” section). Similar ICGC sub-
groups were formed (from cohorts independent of
TCGA), but with the squamous cell carcinoma sub-
group replaced with a carcinoma subgroup, which in-
cludes seven carcinoma cancer studies excluding breast
cancer (see the “Methods” section).
Analogously to the DSB datasets, we determined the
number of tumor SV breakpoints per 50 kb region for
each of the ICGC and TCGA SV datasets (see the
“Methods” section) and compared these to the DSB pre-
dictions from our models. In ICGC data overall we saw
low correlations between the number of SV breakpoints
and DSB predictions (Additional file 1: Figure S8 and S9).
Restricting our analysis to ICGC enriched SV breakpoint
regions, or ESBs for the purpose of this manuscript (50 kb
regions with SV breakpoint counts in the top 5%
genome-wide, see the “Methods” section), increased the
agreement with DSB model predictions. Significant in-
creases in NHEK and MCF7 model predictions were seen
for pancancer, carcinoma, blood, and breast tumor ESBs
and in K562 model predictions for all cancer subsets ex-
cept blood ESBs (Fig. 5). The significant increase in DSB
model predictions seen for carcinoma ESBs indicates that
DSB susceptibility (captured in the models) may shape the
SV landscape of these cancer types. We also see a signifi-
cant increase in DSB predictions for TCGA blood cancer
ESBs, but not for any other subgroups in TCGA data
(Additional file 1: Figure S10). However, as mentioned,
TCGA data is of low resolution and not suitable for accur-
ate breakpoint detection.
Certain classes of relatively simple SVs (deletions, du-
plications, inversions, translocations) are often the
product of one or two DSBs, while more complex
intrachromosomal rearrangements can be difficult to
classify accurately, and may have origins in poorly
understood phenomena such as chromothripsis [41].
Indeed, even for simple SVs, there may be some ambi-
guity, with an unknown fraction arising by mechanisms
that may not involve a DSB. For example, insertions
can arise from transposon activity, and duplications
from replication slippage [42]. However, even if many
SV breakpoints do not arise from DSBs, we might rea-
sonably expect to see shifts to higher median DSB
model prediction values for many simple SV classes.
We determined ESBs as above for ICGC-annotated SV
classes across all ICGC tumor types to examine their
DSB frequency predictions, compared to non-ESBs, 50
kb regions that do not attain SV breakpoint counts in
the top 5% with at least one tumor SV breakpoint de-
tected. Overall, the models show significant elevations
for ESBs covering all SV classes except insertions
(Fig. 5). Insertions may be less influenced by DSB sus-
ceptibility because they may occur via transposable
element activity rather than through DNA damage and
repair pathways. Crosetto et al. [18] find an enrichment
of satellite repetitive elements in regions enriched for
DSB in cells exposed to aphidicolin. However, regions
that undergo DSB under replicative stress, as induced
by aphidicolin, may differ from DSB regions under nor-
mal cell growth conditions.
Fig. 4 DSB models improve predictions for non-model cell types.
Models trained using a dataset from one cell type were used to
generate predictions for a different cell type, given the matched
features. The dark blue lines mark the Pearson’s correlation between
the two cell types. The cell type used to train the model is indicated
by the color of the bar, and the cell type on which the model is
being applied is shown on the x-axis. In all cases, the random forest
model greatly improves the predictions from a naïve inference, with
a 1.3–1.8 fold improvement in correlation
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Interrogating tumor SV data at common fragile sites with
DSB models
The predicted DSB frequencies from our models and
ICGC tumor SV breakpoint frequencies differ in their
scaling and distributions and are not directly compar-
able. However, it is of interest to identify outlier regions,
where model predictions and observed tumor SV break-
point rates diverge most, since these regions may include
loci under selection in tumors. We developed a novel
metric, the d-score, to measure this divergence between
expectations given a DSB model and observed SV break-
point rates in tumors. In brief, this metric relies on fit-
ting known distributions to the observed SV breakpoint
dataset and to the predicted DSB dataset. Based upon
the known distributions we then transform the observed
SV counts and predicted DSB values to p values, reflect-
ing the probability that each value is drawn from the fit-
ted distribution (see the “Methods” section). For each
50 kb region in the genome, the difference between the
SV breakpoint log p value and the predicted DSB log p
value is the d-score. Regions with unexpectedly high
d-scores contain more SV breakpoints than expected,
given our model, whereas regions with unusually low
d-scores contain fewer SV breakpoints than expected.
Common fragile sites (CFSs) have long been studied
for their unusual properties of generating SVs, both
in normal cells and in cancer [38]. These regions
undergo frequent DSBs in tumors and have been well
studied in terms of their genomic context, relation-
ship to replication timing and origins, and correla-
tions with particular chromatin states [43]. They tend
to occur within large genes, in G-negative chromo-
somal bands with high DNA flexibility, are unusually
late replicating [44], and it is thought that their
instability derives from transcription-associated repli-
cation stress [38]. CFSs only exist in modest numbers
and are defined at low resolution (by cytogenetic
bands or gene loci); they, therefore, provide an inter-
esting, though challenging, test set of regions to
examine d-score performance.
Fig. 5 Regions enriched for cancer SV breakpoints (ESBs) display a significant increase in DSB frequency across cancer types. a–c The regions with
ICGC SV breakpoint frequencies in the top 5% are shown with their predicted DSB values as violin plots for each of the three cell type models:
NHEK, K562, and MCF7. ICGC cohorts are shown all together (pancancer) and split into three cancer categories: carcinoma, blood, and breast
cancers (see the “Methods” section). d–f ICGC SV breakpoint counts separated by SV type, and the top 5% of ESBs are shown with their predicted
DSB values as violin plots. The numbers following the x-axis labels are SV breakpoint count cutoffs for the top 5% ESBs, and the numbers in
parenthesis are the number of 50 kb regions that meet the cutoff. For example, there are 225 50 kb regions with more than two SV breakpoints
in blood cancers. Stars indicate significantly higher values in DSB predictions for the ESBs relative to non-ESBs for each category, as determined
by a Wilcox ranked sum test (* for p≤ 0.05, ** for p ≤ 0.01, *** for p≤ 1e−3, and **** for p≤ 1e−4)
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We examined predicted (NHEK model) DSB frequen-
cies at 294 50 kb regions coinciding with annotated CFS
gene loci across the genome, in comparison to regions
associated with all annotated genes, and regions associ-
ated with putative cancer driver genes (Fig. 6c). Al-
though significant shifts to higher frequencies are seen
for the driver gene sets for predicted DSB frequencies,
the CFSs do not show a similar increase, most likely be-
cause the model predicts DSB in early replicating re-
gions, and CFS tend to be late-replicating. Thus, the
dominant features influencing DSB susceptibility
genome-wide do not appear to drive the elevated DSB
rates at CFSs, consistent with CFS instability involving
replicative stress [38]. However, CFS d-scores show a
significant shift above the distribution for all genes and
above the driver gene sets as well (Fig. 6d). This result is
replicated in the MCF7 BLISS model examined in con-
junction with ICGC breast cancer SV breakpoints (Add-
itional file 1: Figure S11). We conclude that the d-score,
a measure of relative DSB enrichment, offers a robust
metric for the classification of regions showing unusual
SV breakpoint rates in tumors.
Identification of hot and cold spots for structural variant
breakpoints in tumors
We have developed a classification of regions of interest
within ICGC tumor cohorts based upon the d-score
metric. We call regions with significantly more SV
breakpoints than expected, or SV hotspots, cancHpredL
(cancer high, predicted low), and regions with fewer SV
breakpoints than expected, or SV coldspots, cancLpredH
(cancer low, predicted high) (see the “Methods” section).
Fig. 6 Inference of positively and negatively selected SV regions. a The predicted DSB frequencies for regions overlapping RefSeq genes, two sets
of cancer consensus genes, and common fragile sites (CFS) are shown as violin plots. The stars represent significantly higher values in the region
subsets, compared to genomic regions that do not overlap the given annotation set, using a Wilcox ranked sum text. b The same regions as in a,
but with d-score values, a measure of the deviation of the observed breakpoint frequencies from the predicted or expected DSB frequencies. c
Observed SV breakpoint frequencies for ICGC carcinomas (excluding breast cancer) with predicted DSB frequencies from the NHEK DSBCapture
model. Each point represents a 50-kb region and is colored by its d-score. Regions were split into high (cancHpredL) and low (cancLpredH) d-
score categories (d-score p value < 0.01), a cancHpredH category, representing regions with d-scores near zero, and a cancHpredL2 category,
representing low mappability regions (see the “Methods” section). d Each category was tested for enrichment of various annotations using
circular permutation (see the “Methods” section). The yellow dotted line marks p < 0.01 significance, and the numbers in parenthesis indicate the
number of 50 kb regions in each category, out of 61,903 in total
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Figure 6 depicts these classes of regions in d-score plots
of ICGC SV breakpoint data. Many previous studies
have predicted oncogenic SV hotspots simply as regions
repeatedly rearranged in cancers. Here, we refine such
predictions by assessing these raw SV breakpoint fre-
quencies relative to the predicted susceptibility of each
region to breakage. It is not possible to predict coldspot
regions without a model of expected DSB frequency,
and to our knowledge, SV breakpoint coldspots have not
been studied before.
We also define a class of regions possessing both high
predicted DSB values and high SV breakpoint frequen-
cies (cancHpredH), corresponding to regions showing
unusually high SV frequencies on the background of
high susceptibility to DSBs. Finally, we define a fourth
class of regions that have predicted DSB rates close to
zero but high SV breakpoint frequencies (cancHpredL2).
In principle, these regions are a class of SV hotspots but,
as shown in Fig. 3b, they are likely to be repetitive, het-
erochromatic, and enriched for artifacts (false positives
and negatives in SV breakpoint) due to their association
with low mappability.
We examined a range of functional annotation enrich-
ments in the four classes of regions using circular per-
mutation to assess significance (see the “Methods”
section; Fig. 6). The annotations included two putative
cancer gene sets, 260 genes from the Cancer5000 dataset
[45] and 561 genes from the COSMIC collection [46]).
We also included a set of 15,415 super enhancers [47],
common fragile sites, and chromatin states from EN-
CODE chromHMM analysis [48]. Notably, the majority
of genes in both cancer sets are predicted to be onco-
genic based on unexpectedly high and functionally sig-
nificant SNV (rather than SV) loads and are not
necessarily expected to occupy regions with higher levels
of SV breakpoints. In fact, both gene sets demonstrate
significant enrichments in the cancHpredL class of hot-
spot regions (Fig. 6d), although RefSeq genes do not,
suggesting that these genes may also frequently be al-
tered in cancer through SV. The cancHpredL regions
are also significantly depleted in active chromatin re-
gions, such as promoters, enhancers, and insulator re-
gions, most likely because these types of regions do not
have low predicted DSB. The high susceptibility cancH-
predH regions occupy gene-rich areas of the genome
(enriched for known RefSeq genes) including both can-
cer genes sets, and for active promoters, strong en-
hancers, and insulators. This is consistent with reports
that CTCF bound insulator elements suffer recurrent
mutations in tumors. Likewise, the cancLpredH class of
coldspot regions occupies gene-rich neighborhoods, ac-
tive promoters, and strong enhancers (Fig. 6), suggesting
some genes and distal regulatory regions may have expe-
rienced purifying selection in tumors.
Given the discrepancies mentioned above between
ICGC and TCGA experimental platforms, data analysis,
and sample cohorts, we do not expect strong agreement
between ICGC and TCGA derived SV datasets. Indeed,
the correlation between them is low (Spearman’s rho of
0.099, p < 2.2e−16), and the pancancer ESBs from either
set do not significantly overlap (p < 0.99, see the
“Methods” section ). However, the cancLpredH class is
again enriched in active promoter and strong enhancer
regions, in accordance with the results based upon
ICGC SV data (Additional file 1: Figure S12).
We again wanted to test the utility of DSB random
forest models applied to different cell types by testing
the accuracy of predictions made by a model trained in
one cell type given features for a different cell type, as in
Fig. 4. Instead of looking at the correlation between the
observed and predicted DSB scores across the genome,
we examined the overlap between cancHpredL, cancH-
predH, and cancLpredH 50 kb regions for the MCF7
model versus the NHEK model, using the MCF7 model
as the truth set. Subsets of 50 kb regions for each model
were derived from MCF7 features and ICGC breast can-
cer SV breakpoints; only the training data for the models
differ. We found a significant overlap between all three
categories of d-score subsets, with 595/662 cancHpredL,
255/785 cancHpredH, and 253/594 cancLpredH regions
detected via the NHEK model (p < 2.2e−16), demonstrat-
ing that a given model can be used to detect regions of
interest in various cell types.
Functional annotation of regions of interest
We closely examined the ten 50 kb regions with the
highest (cancHpredL) d-scores to uncover genes that
might be reclassified as oncogenic due to a higher than
expected SV breakpoint frequency in cancer. Likewise,
we investigated the ten regions with the lowest d-scores
(cancLpredH), which we predict to be under purifying
selection, for signals of potential functionality. For this
analysis, we used the NHEK model predictions paired
with ICGC carcinoma SV breakpoints.
Nine out of ten regions with the highest d-scores over-
lap a gene, and four overlap COSMIC genes. CHEK2
and CDKN2A are known tumor suppressors, and
TMPRSS2 and ERG are frequently involved in transloca-
tion events forming fusion oncogenes in certain cancers.
For example, it fuses with TMPRSS2 in most prostate
cancers, with EWS in Ewing’s sarcoma, and with FUS in
AML. Two adjacent 50 kb regions on chr17q12 overlap
GRB7 and IKZF3. GRB7 encodes a protein that interacts
with epidermal growth factor receptor (EGFR), a
well-known proto-oncogene, and IKZF3 is a zinc finger
protein and transcription factor involved in B lympho-
cyte regulation and differentiation as well as chromatin
remodeling. This region also corresponds to a known
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fragile site FRA17A [49]. Of the ten regions with the
lowest d-scores, seven overlap a known gene and two
known oncogenes. The oncogene, CDC27, or cell div-
ision cycle 27, encodes a component of the APC and has
been shown to interact with other mitotic checkpoint
proteins. It is highly conserved and may be necessary for
cell survival. There is also a non-coding RNA found on
chr2 in the centromeric region, LOC654342, which over-
laps an H3K27ac peak, and may be acting as a regulatory
element.
Discussion
Recent in vitro studies of DSB frequency in cell lines
have suggested that a variety of underlying genomic fea-
tures are associated with DSB susceptibility. We have
shown that accurate models of genome-wide DSB fre-
quency can be built from a modest number of such fea-
tures, with replication timing, open chromatin, and
marks of active promoter or enhancer regions associated
with increased DSBs. Although active regulatory regions
often harbor actively transcribed genes, it appears that
chromatin accessibility at these sites rather than tran-
scription itself determines DSB propensity. The variable
importance metrics also show certain features to be
more influential in particular cell types, with CTCF and
H3K36me3 having more predictive power in MCF7 than
in NHEK or K562. Not only are DSB patterns cell type
specific, but the factors influencing those patterns also
depend on cell type, suggesting different mutational
mechanisms at play. As a matter of course, our models’
accuracies decline when applied to cell lines other than
the training set, but they still generate reasonable DSB
frequency predictions, with correlations between 0.57
and 0.83 to the observed data, which are large improve-
ments over a simple inference. Since chromatin features
influence mutation patterns and are cell type-specific, it
will be important to use mutational propensity profiles
for matched cell types in future cancer studies. In gen-
eral, caution should be exercised in extrapolating from
the currently small number of models to more poorly
characterized cell types lacking experimentally deter-
mined DSB data.
Our models of genome-wide DSB susceptibility predict
DSB frequencies for all 50 kb loci and reflect the estab-
lished correlations between replication timing and DSB
frequency [50] as well as tumor SV rates [9, 10]. A re-
cent complementary study has shown that 84,946 high
confidence peaks of NHEK DSBCapture signal [22],
marking small (median: 391 bp) sites of unusually high
DSB susceptibility, can be accurately classified from con-
trol sites using underlying genomic features [34]. Con-
sistent with our results, this binary classifier suggested
prominent roles for DNase accessible regulatory sites
and CTCF binding and recapitulated many of the
patterns reported by Lensing et al. (2016). However, the
model of Mourad et al. (2018) omitted replication timing
and does not provide quantitative predictions of DSB
susceptibility across the genome.
We used our genome-wide models of DSB susceptibil-
ity to interrogate the largest tumor SV breakpoint collec-
tions and found surprising levels of agreement, such that
SV breakpoint enriched regions often show shifts to
higher predicted DSB susceptibility. In spite of variable
sample sizes, the classes of simple SV likely to arise by
one or two DSBs (deletions, duplications, inversions,
translocations) showed significant increases in predicted
DSB susceptibility. The NHEK model best predicted the
patterns of DSB susceptibility in tumors, showing
genome-wide elevations of predicted DSBs for all of
these SV classes relative to control regions. Thus, the
chromatin-mediated DSB susceptibility captured in the
model may shape the landscape of SV recurrence in
these classes.
There are many reasons why one might expect a much
poorer agreement between the predictions of in vitro
DSB frequency models and the patterns of SV break-
points observed in tumor sequencing studies. The avail-
able collections of SV breakpoints in tumors are far
from perfect, and even the best ICGC data suffer large
variations in sample size, sample heterogeneity, sequen-
cing depths, and SV calling methods across tumor co-
horts. In addition, fundamental aspects of tumor biology
(cellular heterogeneity, disrupted repair pathways, chro-
matin alterations etc.) are expected to place distinct
limits on the agreement we can see with the DSB pat-
terns seen in cell lines. Evidence is also emerging that
there are important properties of the mutational land-
scape in tumors that are unlikely to be captured by in
vitro model systems. For example, a recent study of
intra-tumor diversification in colorectal cancer suggests
that most mutations occur during the final clonal expan-
sion of these tumors, resulting from mutational pro-
cesses that are absent from normal colorectal cells [51].
Enhanced rates of DSB formation have also been ob-
served in vitro at cryptic replication origins activated by
oncogene-induced replication stress, though these cryp-
tic sites seem to explain only a minority of SV break-
points (< 8%) across a variety of TCGA tumor types [52].
Given the many known and possible differences between
in vitro DSB model predictions and observed tumor SV
breakpoints, it is remarkable that significant agreement
is found on any level.
There is great interest in “hotspot” genomic regions
harboring recurrent SVs in tumors, on the basis that
such regions may be under positive selection, conferring
a proliferative or survival advantage to tumor cells.
However, a rigorous inference of selection requires a
proxy for the expected rate of recurrence within such
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regions. Using model predictions as this proxy we have
produced refined hotspot predictions, reflecting SV
breakpoint frequencies relative to the predicted suscepti-
bility of each region. Since our predictions of DSB sus-
ceptibility are genome-wide it was also possible to
predict coldspot regions, regions possessing unexpect-
edly low SV breakpoint rates given model predictions,
and putatively subject to negative or purifying selection
in tumors. If selection in tumors is prominent in driving
SV breakpoint frequencies away from DSB model
predictions, we might expect hotspot and coldspot re-
gions to show unusual functional enrichments. Multiple
caveats apply to the annotations examined but analysis
using the NHEK model shows that ICGC carcinoma
hotspots are enriched for putative oncogenes. Coldspots
occupy gene-rich neighborhoods but and are also
enriched in active promoters and strong enhancers, and
insulators, indicating regulatory regions that may have
experienced purifying selection in tumors. Methods for
the detection of DSBs in human cells, as well as the
causes and consequences of these mutations, remain
active areas of fundamental research. Further develop-
ment of both in vitro and in silico model systems will
undoubtedly provide new insights into somatic muta-
tion and repair processes and their significance to
tumorigenesis.
Conclusions
When inferring selection on single nucleotide variants it
is standard practice to make comparisons between the
observed variant frequencies and the frequencies ex-
pected, according to a model of single nucleotide muta-
tion rates. We have developed models of DSB mutation
rates that can be used to generate expected SV break-
point frequencies and illuminate regions with significant
deviations from these expectations. This approach pro-
vides statistically rigorous protocols to prioritize novel
loci putatively under selection in tumors, generating
testable hypotheses for further experimental studies.
Methods
Derivation of DSB data in the K562 and MCF7 cell lines
DSB profiles were generated with an adapted version of
the Breaks labeling in situ and sequencing protocol [25],
in which DSB ends are labeled with a dsDNA BLISS
adapter in cell suspensions of one million cells. After-
wards, the published protocol is followed with only
minor modifications. Labeled DSBs are selectively ampli-
fied using T7-driven linear amplification, after which se-
quencing libraries are generated and sequenced with
single-end 1 × 75 v2 chemistry on an Illumina NextSeq
500. Raw sequencing reads were demultiplexed by Illu-
mina’s BaseSpace, after which FASTQ files were down-
loaded and processed as described in Yan et al. 2017
(SRA accession SRP150602). In brief, reads with the ex-
pected prefix of 8 nt UMI and 8 nt sample barcode se-
quence were filtered using SAMtools and scan for
matches, allowing at most one mismatch per barcode.
Trimmed reads were then aligned to GRCh37 using bwa
mem, and reads with mapping scores below 30 were dis-
carded. Next, PCR duplicates were identified by search-
ing for proximal reads (within 30 bp of the reference
genome) with at most two mismatches in the UMI se-
quence, which were then grouped and collapsed into a
single break location. Finally, we generated .bed files
with DSB locations and the number of unique UMIs in-
dicating that location.
Generating random forest models
We downloaded ten tracks from ENCODE for multiple
chromatin marks, replication timing, open chromatin, sev-
eral DNA binding proteins, and nucleosome pull-downs
from the UCSC genome browser [53]. We used
G-quadruplex data generated by Chambers et al.,
(GSE63874). In their study, they make separate .bedgraph
files available with the G-quadruplex density for each
strand. We used the sum of the plus and minus strands in
our analysis. The list of bigwig files used for each cell line
along with their sources and graphical labels is in Add-
itional file 2: Table S1. We used the bigWigAverageO-
verBed tool from the kentUtils tool library to produce
average signal per 50 kb in non-overlapping windows
across hg19 for each track. We combined the results to a
single matrix per cell line composed of 61,903 rows, one
for each 50 kb bin, and 11 columns, one for each chroma-
tin or genomic feature. These feature matrices are avail-
able as supplementary data [54] and scatter plots of each
feature with the NHEK DSBCapture data are shown in
Additional file 1: Figure S3.
For the extended model in Additional file 1: Figure S4,
we downloaded an additional nine features from the
UCSC genome browser [53], which were processed in
the same way as the ten ENCODE features used in the
primary feature matrix. We also downloaded .hic files
for NHEK, K562, and HMEC cells generated from Rao
et al. (GSE63525). We used their custom toolbox, Juicer,
to calculate eigenvectors per chromosome, and gener-
ated 50 kb resolution eigenvector profiles using the bed-
GraphToBigWig and bigWigAverageOverBed tools from
kentUtils. The figure labels and sources for these data
are in Additional file 2: Table S2, and the extended fea-
ture matrices are in supplementary data [54].
We generated DSB frequency scores from each of the
four HTS DSB profiling datasets: two in NHEK cells,
one for K562, unpublished, and one for MCF7, unpub-
lished. As mentioned in the results, two replicates for
each of two DSB HTS profiling methods, DSBCapture
and BLESS, were available from Lensing et al. [22]. We
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took the average per 50 kb of the replicates to create an
NHEK DSBCapture profile and an NHEK BLESS profile.
We combined three replicates of MCF7 BLISS data (via
a sum operation) to serve as our MCF7 DSB profile. A
fourth MCF7 BLISS dataset is available, but we excluded
it from our analysis because it had a distinctly lower cor-
relation to the other three datasets (0.90–0.92 as op-
posed to 0.97–0.99). These scores are available as
supplementary bedgraph files [54].
We used the randomForest package in R to generate ran-
dom forest models with 500 trees and five OOB permuta-
tions per tree (options ntree = 500, nPerm= 5). To calculate
variable importance, we used the importance command
within the randomForest package (https://cran.r-projec-
t.org/web/packages/randomForest/index.html), which cal-
culates the average prediction error rate (MSE) for each
datapoint (50 kb bin) across all trees in the random forest.
Then, for each feature variable, the values are randomly
permuted and the MSE for each 50 kb bin is calculated
again. The final variable importance score is the average dif-
ference in MSE before and after the permutation, normal-
ized by the standard deviation of these differences. Because
many features are inter-correlated, their importance mea-
sures were very similar. Therefore, in order to determine a
consistent ranking of features’ importance values, we gener-
ated ten random forest models per dataset and calculated
the average and standard deviation of importance across
the ten models.
Although random forest models are not susceptible to
overfitting, to confirm that our models were not overfit to
the DSB data, we also generated a random forest model
for the NHEK DSBCapture dataset, holding out one third
of the data as the test set and training the model on the
remaining two thirds. This model showed 0.93 Pearson’s
correlation between the predictions and the observed data
for the training set, similar to the model trained on the full
dataset (Additional file 1: Figure S5).
Determining tumor ESBs and their predicted DSB scores
To determine SV DSB rates from TCGA data, we down-
loaded CNV data from TCGA [55], which came from
Affymetrix SNP 6.0 arrays processed by the DNAcopy
R-package (https://docs.gdc.cancer.gov/Data/PDF/Data
_UG.pdf ). DNAcopy generates a set of continuous seg-
ments, outputting regions with little or no copy number
change, so we filtered these, defining segments with a
CN ratio > 1 as amplifications and ratios < − 1 as dele-
tions. The segments were lifted from hg38 to hg19 using
UCSC’s liftOver tool. For each CNV, we counted a single
DSB to occur in a 50 kb bin if either or both ends of the
segment overlapped the bin. The TCGA-BLOOD group
includes the two blood cancer cohorts: acute myeloid
leukemia (LAML) and lymphoid neoplasm diffuse large
B cell lymphoma (DLBC), while the TCGA-SCCA group
includes three squamous cell carcinomas: cervical squa-
mous cell carcinoma and endocervical adenocarcinoma
(CESC), head and neck squamous cell carcinoma
(HNSC), and lung squamous cell carcinoma (LUSC).
The BRCA group includes only the TCGA breast cancer
cohort (BRCA), and the PANC group includes all 33
cancer types, shown in Additional file 1: Figure S7.
Counts for various groups and CNV types are available
as supplementary data [54].
We downloaded available WGS SV calls from the
ICGC Data Portal (https://dcc.icgc.org/projects). As with
the TCGA CNV, a single DSB was counted per 50 kb bin
if either one or two ends of a SV overlapped the region.
The ICGC pancancer group contains SVs from 17 can-
cer studies, shown in Additional file 1: Figure S6. The
carcinoma group contains all available carcinoma cancer
studies, excluding breast cancer: early-onset prostate
cancer (EOPC-DE), liver cancer (LIRI-JP), pancreatic
cancer (PACA-CA, PAEN-AU, PAEN-IT), prostate can-
cer (PRAD-CA, PRAD-UK), and skin adenocarcinoma
(SKCA-BR). The ICGC blood group contains chronic
lymphocytic leukemia (CLLE-ES) and malignant lymph-
oma (MALY-DE), and the breast group contains breast
cancer studies (BRCA-EU and BRCA-FR). A table of
DSB counts per 50 kb broken up by group and SV type
is in supplementary data [54].
We determined enriched SV breakpoint regions (ESBs)
per cohort or SV type grouping by ranking the 50 kb
bins by the number of DSB, excluding regions with no
DSB in the group, and using the number of DSB in the
top 5% as the cutoff. All 50 kb regions with a DSB count
greater than or equal to the cutoff were designated ESBs.
We used a Wilcoxon ranked sum test (R wilcox.test
command) to test for a significant increase in the pre-
dicted DSB values for ESBs compared to all other re-
gions, and we excluded regions in which no DSB were
found in any cancer study since these are likely to be
unmappable or blacklisted regions.
The correlation between TCGA and ICGC pancancer
SV breakpoint counts was calculated using Spearman’s
rho and excluding 50 kb regions with no SV breakpoints
in either the TCGA or ICGC datasets. The top 5% ESBs
were found for each dataset, with 2839 regions found in
TCGA and 3072 in ICGC, and the significance of the
overlap was calculated using a hypergeometric test (R
command phyper with q = 177, m = 2839, n = 61,903–
2839, and k = 3072).
Calculating d-scores
We used the R package fistdistrplus [56] to determine
the distributions with the best fit to the DSB prediction
values and the SV breakpoint frequencies. We used a
likelihood maximization test (method = “mle”) and the
BIC (Bayesian Information Criterion) measure of
Ballinger et al. Genome Biology           (2019) 20:28 Page 12 of 15
goodness of fit to choose the best distribution. We tested
a lognormal, log-logistic, gamma, normal, and an expo-
nential distribution, and fitted the distributions to the
bulk of the SV breakpoint or DSB prediction data. We
excluded 50 kb regions with breakpoint frequencies
greater than six times the interquartile range from the
median in order to exclude extreme outliers. While we
aimed to emphasize the fit of the tails of our data’s dis-
tributions, including these outliers resulted in poorly fit-
ting distributions to the bulk of the real data. Once we
found the best of the three candidate model distribu-
tions, we assigned a p value to each 50 kb bin from the
fitted distribution (using the plnorm, pllogis, or pgamma
functions in R) which represent the probability of seeing
a given breakpoint frequency or DSB prediction or
greater in the known distribution. The actual and fitted
distributions and quantile-quantile plots are shown in
Additional file 1: Figure S13 and S14.
Next, for each 50 kb bin, we calculated the difference in
log p values between the predicted DSB and the actual SV
breakpoints, called d-scores. Using the fistdistrplus R pack-
age again, we determined the best-fit distribution for the
d-scores, choosing between a t-distribution, a normal, and
a Cauchy distribution. Again, we used a maximum likeli-
hood method and the BIC measurement and excluded
extreme outliers. In all cases, a t-distribution with four de-
grees of freedom (df = 4) was the best fit, so each 50 kb bin
was assigned a p value from this distribution according to
its d-score. The histograms and quantile-quantile plots of
the d-scores and fitted distributions are shown in
Additional file 1: Figure S15.
Calculating gene set and chromatin domain enrichments
We used the d-score p values to categorize regions into
informative subsets, using the R command qt (p = 0.01,
df = 4, lower.tail = FALSE) to determine the d-score cut-
offs. The cancHpredL class of regions have d-scores in
the upper one percentile (> 3.75), and the cancLpredH
have d-scores in the lower one percentile (< − 3.75). The
cancHpredH class has d-scores in the 40th to 70th per-
centiles and SV breakpoint frequencies or DSB predic-
tions with p values less than 0.01, so these regions have
significantly (p value < 0.01) high SV breakpoints or DSB
predictions but insignificant d-scores (p value < 0.6). The
cancHpredL2 class consists of regions with SV break-
point p values less than 0.01, and DSB predictions less
than 0.5 for the NHEK models and less than 0.001 for
the MCF7 model.
We used a binomial test to measure the significance of
overlaps between sets when comparing results from the
MCF7 model and the NHEK model applied to ICGC
breast cancer data and MCF7 cell line features (R com-
mand binom.test).
We used the R package regioneR [57] to compute the
overlap significance between each set of regions and vari-
ous genome and chromatin annotation files. A list of
annotation sets and their original sources are in
Additional file 2: Table S3. We matched Cancer5000 genes
and Cosmic gene lists to RefSeq gene names in order to
get their genome coordinates, so the cancer gene lists are
RefSeq gene subsets. The super enhancer set (SEA) came
from A549 cells, derived from a lung carcinoma [47].
Common fragile sites (CFS) were collected from NCBI’s
gene archive by searching for “common fragile site” or
“fragile site” within human genes. Many fragile sites are
annotated by chromosome band but do not have exact co-
ordinates; we filtered these out because they are low reso-
lution. The chromHMM [48] annotation came from the
UCSC genome browser. We tested enrichment of the
NHEK states with the NHEK model d-score classes and
the HMEC track, from primary mammary epithelial cells,
with the MCF7 model’s d-score classes. The regioneR
package performs random circular permutation of regions
of interest and then computes the number of overlaps be-
tween the permutated set and a second set of regions. The
p value represents how often, over the course of the per-
mutations, the two sets overlap to the same extent that
they do without any permutation. We used 1000 iterations
to achieve a maximum p value of 0.001.
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